Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus

被引：57

作者：

Cheung, N. Wah ^{[1
,2
]}

Conn, Jennifer J. ^{[3
]}

d'Emden, Michael C. ^{[4
]}

Gunton, Jenny E. ^{[1
,2
,5
]}

Jenkins, Alicia J. ^{[6
]}

Ross, Glynis P. ^{[7
,8
]}

Sinha, Ashim K. ^{[9
]}

Andrikopoulos, Sofianos ^{[10
]}

Colagiuri, Stephen ^{[11
]}

Twigg, Stephen M. ^{[2
,7
]}

机构：

[1] Westmead Hosp, Dept Endocrinol & Diabet, Sydney, NSW, Australia

[2] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia

[3] Royal Melbourne Hosp, Melbourne, Vic, Australia

[4] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia

[5] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia

[6] Univ Melbourne, Dept Med, St Vincents Hosp, Melbourne, Vic, Australia

[7] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia

[8] Bankstown Lidcombe Hosp, Sydney, NSW, Australia

[9] Cairns Base Hosp, Cairns, Qld, Australia

[10] Univ Melbourne, Dept Med, Heidelberg Repatriat Hosp, Melbourne, Vic, Australia

[11] Univ Sydney, Boden Inst Obes Nutr & Exercise, Sydney, NSW 2006, Australia

来源：

MEDICAL JOURNAL OF AUSTRALIA | 2009年 / 191卷 / 06期

关键词：

BLOOD-GLUCOSE CONTROL; CARDIOVASCULAR-DISEASE; COMPLICATIONS; ASSOCIATION; METFORMIN; MORTALITY; INSULIN; TYPE-1; TRIAL; WOMEN;

D O I：

10.5694/j.1326-5377.2009.tb02819.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Tight glycaemic control reduces the risk of development and progression of organ complications in people with type 1 or type 2 diabetes. In this position statement, the Australian Diabetes Society recommends a general target glycated haemoglobin (HbA(1c)) level of <= 7.0% for most patients. This position statement also provides guidelines for the individualisation of glycaemic targets to a tighter or lesser degree, with a recommended target HbA(1c) level of <= 6.0% in some people, or up to <= 8.0% in others. Individualisation of the HbA(1c) target is based on patient-specific factors, such as the type of diabetes and its duration, pregnancy, diabetes medication being taken, presence of cardiovascular disease, risk of and problems from hypoglycaemia, and comorbidities. Management of diabetes also includes: adequate control of other cardiovascular risk factors, including weight, blood pressure and lipid serum levels; antiplatelet therapy; and smoking cessation. MJA 2009; 191: 339-344

引用

页码：339 / 344

页数：6

共 25 条

[1] Poor pregnancy outcome in women with type 2 diabetes [J].